AMZN
Amazon.com, Inc.
AMZN has the edge over VSXY overall, supported by stronger valuation and lower modeled downside.
VSXY
Victoria's Secret & Company
VSXY offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
VSXY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
VSXY's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over VSXY in the historical PE scenario, which offers more potential upside but is not a forecast.
VSXY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.8x | $30.32 | -71% |
| Fair | 14x | $60.95 | -42% |
| Forward | 20x | $105 | — |
| Current | 23x | $105 | — |
| Expensive | 24x | $108 | +3.3% |
Historical ranges are pointers, not guarantees.
VSXY's PE is in its expensive range at 23x. If earnings grow as analysts expect, today's price would be 20x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
VSXY Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
VSXY has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over VSXY on earnings, with more consistent year-over-year improvement.
VSXY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.24 | +17% |
| Q3 2026 | $4.49 | +139% |
| Q2 2026 | $2.51 | +21% |
| Q1 2026 | $1.93 | -5.9% |
| Q4 2025 | $2.13 | +8.7% |
| Q3 2025 | $1.88 | +7.4% |
| Q2 2025 | $2.08 | +56% |
| Q1 2025 | $2.05 | +47% |
| Q4 2024 | $1.96 | +69% |
VSXY's earnings per share have fallen from their peak: $4.49 over the past year, against $6.15 in early 2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over VSXY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
VSXY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +10% |
| Q2 2026 | $1.6B | +15% |
| Q1 2026 | $2.3B | +7.7% |
| Q4 2025 | $1.5B | +9.3% |
| Q3 2025 | $1.5B | +3% |
| Q2 2025 | $1.4B | -0.4% |
| Q1 2025 | $2.1B | +1.1% |
| Q4 2024 | $1.3B | +6.5% |
VSXY's revenue has grown year over year for five quarters in a row: $1.6B last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | +13 points |
| Q2 2026 | 4.9% | +3.4 points |
| Q1 2026 | 10% | -2.6 points |
| Q4 2025 | -1.3% | +2.2 points |
| Q3 2025 | 2.8% | -1.6 points |
| Q2 2025 | 1.5% | -0.4 points |
| Q1 2025 | 13% | +0.3 points |
| Q4 2024 | -3.5% | +1.8 points |
VSXY has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
VSXY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $328M | +273% |
| Q2 2026 | -$191M | +$2M |
| Q1 2026 | $649M | +0.5% |
| Q4 2025 | -$232M | +$67M |
| Q3 2025 | $88M | +60% |
| Q2 2025 | -$193M | -$38M |
| Q1 2025 | $646M | +16% |
| Q4 2024 | -$299M | -$38M |
VSXY has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over VSXY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
VSXY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -1M shares |
| 1 year | +2.4% | +2M shares |
| 3 years | +9.1% | +7M shares |
| 5 years | -4.9% | -4.4M shares |
VSXY has 84M diluted shares, up 2.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $100M |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
VSXY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 0.9x | Very low |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 2.2x | Moderate |
VSXY has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
VSXY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.4 | Neutral |
| Stochastic | 83.0 | Overbought |
VSXY's weekly RSI is 65 (neutral) and its Stochastic is 83 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over VSXY on valuation relative to its sector.
VSXY PE vs Consumer Cyclical Sector
| Metric | VSXY | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 29% above |
| PE % | 82 | 55 | 27 pts above |
VSXY is trading at 23x earnings, a 29% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
VSXY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $93.1 | 12% above |
| 20 week MA | $87.2 | 20% above |
| 50 week MA | $69.2 | 51% above |
| 100 week MA | $47.9 | 119% above |
| 200 week MA | $36.4 | 188% above |
VSXY is in an uptrend: it's above all five of its weekly moving averages, and 188% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
VSXY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $42.1 | $49.1 | +17% |
| 2022 | $49.1 | $40.4 | -18% |
| 2023 | $40.4 | $26.5 | -34% |
| 2024 | $26.5 | $42.3 | +59% |
| 2025 | $42.3 | $53.8 | +27% |
| 2026 YTD | $53.8 | $104.6 | +94% |
VSXY has the edge over AMZN on returns for 2026, with the stronger performance.